popular stocks to invest in

A Vancouver based mineral exploration company, Nexus Gold focuses its efforts on the worlds most prolific exploration and mining districts. Nexus is currently developing two projects in Burkina Faso, West Africa. Located on the Boromo greenstone belt, the Niangouela gold concession is proximal to the Kalsaka deposit and the Sabce shear.

Nexus Gold is featuring numerous near-surface gold occurrences of both length and grade, as highlighted by historical drill results. Previously explored by Riverstone Resources and Roxgold Inc., the property contains three distinct gold trends, each extending 5 kilometers in length.

The Niangouela gold exploration permit covers 178 square kilometers. To date, a total of 1,173 gold samples have been collected. Nexus Gold completed its initial sampling in December of 2016. This sampling included an 800m Rotary Air Blast (RAB) drill program. These samples returned high-grade mineralization.

popular stocks to invest in: Haynes International, Inc.(HAYN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Basic materials sector was the top gainer in the US market on Monday. Top gainers in the sector included Haynes International, Inc. (NASDAQ: HAYN), Cliffs Natural Resources Inc (NYSE: CLF), and Olympic Steel, Inc. (NASDAQ: ZEUS).

  • [By Lisa Levin]

    In trading on Wednesday, basic materials shares fell by 1.24 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 12 percent, and McEwen Mining Inc (NYSE: MUX), down 9 percent.

  • [By Lisa Levin]

    In trading on Tuesday, basic materials shares fell 0.44 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 5 percent, and Gibraltar Industries Inc (NASDAQ: ROCK), down 4 percent.

popular stocks to invest in: Akebia Therapeutics, Inc.(AKBA)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Keith Speights]

    You might not have heard too much about Akebia Therapeutics (NASDAQ:AKBA), BioMarin Pharmaceutical (NASDAQ:BMRN), and Idera Pharmaceuticals (NASDAQ:IDRA). These are three biotech stocks that you could be overlooking — but deserve your attention. Here’s why.

  • [By Todd Campbell]

    After inking an expanded deal withOtsuka Pharmaceutical on its midstage anemia drug, shares ofAkebia Therapeutics (NASDAQ:AKBA)skyrocketed 33.4% today.

  • [By Lisa Levin]

    Shares of Akebia Therapeutics Inc (NASDAQ: AKBA) got a boost, shooting up 39 percent to $13.04. Akebia Therapeutics and Otsuka disclosed that they have expanded relationship with collaboration to develop and commercialize Vadadustat in Europe, China and other territories.

popular stocks to invest in: Myriad Genetics, Inc.(MYGN)

Advisors’ Opinion:

  • [By Cory Renauer]

    Shares of Myriad Genetics, Inc. (NASDAQ:MYGN), a DNA diagnostics specialist, dropped 61.4% last year, according todata from S&P Global Market Intelligence.Efforts to offset hereditary cancer-testing segment losses just weren’t successful enough to keep profits, and the stock, from sliding last year.

popular stocks to invest in: Axsome Therapeutics, Inc.(AXSM)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, ourUnder the Radar Moversnewsletter suggested shorting small cap clinical-stage biopharmaceutical stock Axsome Therapeutics (NASDAQ: AXSM):

  • [By Lisa Levin]

    Axsome Therapeutics Inc (NASDAQ: AXSM) shares dropped 18 percent to $3.62. Axsome Therapeutics priced 3.74 million shares at $3.74 per share.

    Shares of Canadian Solar Inc. (NASDAQ: CSIQ) were down around 11 percent to $12.10 after the company posted downbeat quarterly earnings and issued a weak forecast.

popular stocks to invest in: Ethan Allen Interiors Inc.(ETH)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Wednesday was a strong day for the stock market, as the Dow finished up nearly 100 points and the S&P 500 and Nasdaq both posted gains as well. Investors remained generally upbeat about the prospects for the U.S. economy in 2017, and a rise in crude oil prices helped lift the energy sector higher during the market session. Yet comments during a press conference from President-elect Donald Trump weighed on the healthcare sector, and some individual stocks took particularly hard hits. Among the worst performers were Perrigo (NYSE:PRGO), Novadaq Technologies (NASDAQ:NVDQ), and Ethan Allen Interiors (NYSE:ETH). Below, we’ll look more closely at these stocks to tell you why they did so poorly.

popular stocks to invest in: Fossil Inc.(FOSL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After running through their scenarios,Boruchow comes up with five losers from Trump’s tax plans: Carters (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil Group (FOSL) and Gap (GPS). He explains why:

  • [By Nicholas Rossolillo]

    Wearable devices are quickly becoming mainstream technology, with smartwatches and fitness trackers leading the way. You’d never know that based on the performance of traditional watchmaker Fossil Group (NASDAQ:FOSL) as the company is struggling to adapt to the changing times.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, NVIDIA (NASDAQ:NVDA) and Fossil Group(NASDAQ:FOSL) attracted heavy investor interest following their quarterly earnings reports.

  • [By Paul Ausick]

    Fossil Group Inc. (NASDAQ: FOSL) dropped nearly 25% Wednesday to post a new 52-week low of $13.65 after closing at $18.15 on Tuesday. The stock’s 52-week high is $36.87. Volume was more than 5 times the daily average of around 1.9 million shares. The company missed analysts’ expectations bigly this morning.

  • [By Lisa Levin]

    Fossil Group Inc (NASDAQ: FOSL) was down, falling around 21 percent to $14.32 after the company posted downbeat quarterly results and issued a weak outlook for the second quarter.

  • [By Shah Gilani]

    That’s amazingly close to the definition I’d give the once-trendy watch and accessories purveyor turned dinosaur crap retailer, Fossil Group Inc.(Nasdaq: FOSL).

Leave a Reply

Your email address will not be published. Required fields are marked *